Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2778-2786
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2778
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2778
Table 2 Main causes of death
| Causes of death | OS < 160 days | OS > 160 days | ||||
| TIPS | Standard treatment | P value | TIPS | Standard treatment | P value | |
| Rebleeding, n (%) | 2 (14.3) | 27 (90.0) | < 0.05 | 1 (6.7) | 6 (33.3) | < 0.05 |
| Liver failure or hepatic encephalopathy, n (%) | 11 (78.6) | 2 (6.7) | < 0.05 | 11 (73.3) | 5 (27.8) | < 0.05 |
| Unknown, n (%) | 1 (7.1) | 1 (3.3) | > 0.05 | 3 (20.0) | 7 (38.9) | > 0.05 |
- Citation: Wu ZQ, Wang F, Wang FP, Cai HJ, Chen S, Yang JY, Guo WB. Transjugular intrahepatic portosystemic shunt for esophagogastric variceal bleeding in patients with hepatocellular carcinoma and portal vein tumor thrombus. World J Gastrointest Surg 2024; 16(9): 2778-2786
- URL: https://www.wjgnet.com/1948-9366/full/v16/i9/2778.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i9.2778